2024 annual financial data
Eupraxia Pharmaceuticals 2024 Revenue growth
Direct answer
Revenue growth was Not calculable.
Operating income was -26,985,284 USD and net income was -25,485,416 USD.
Operating cash flow was -29,994,491 USD.
Get free Eupraxia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,985,284 USD
- Net income
- -25,485,416 USD
- Operating cash flow
- -29,994,491 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Eupraxia Pharmaceuticals financial years